Crown Aesthetics unveiled the results of a new study in the Journal of Cosmetic Dermatology showcasing the efficacy of its Xycrobe technology, formulated to address the often overlooked skin biome. Xycrobe technology targets certain skin conditions and cosmetic treatments using an isolated, living strain of skin-relevant bacteria. The results of the recently published study demonstrate that the BIOJUVE regimen, which incorporates the Xycrobe strain as well as its ferment, supports a healthy skin environment, promotes increased skin hydration, decreases redness, regulates sebum production, and reduces the appearance of signs of aging, such as fine lines and photodamage. "The research we present in this paper debunks numerous myths that have perpetuated for the last half century or so about what constitutes a healthy skin microbiome, what role C. acnes strains play in skin health, and the ability to formulate progressive topicals with live microbes that might contribute to a healthier skin biome overall," says Dr. Thomas M. Hitchcock, Ph.D, chief science officer, Crown Laboratories. "We firmly believe that Crown Laboratories is pioneering the 'skin biome care' category with our extensive research into the skin biome. We aim to continue to invest in exploring the relationship between the microbes that live on and in the skin, and how this new philosophy of formulating topicals to holistically consider the skin biome may change how we care for the skin. We believe Xycrobe technology fulfills the skin biome needs outlined by our research, and we are very excited to share this data and the BIOJUVE products used in the clinical study, with the world."